Granata Bio Corporation
$5.5K 22 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. reported $5,489.18 across General Payments, Research, and Ownership to 214 physicians and teaching hospitals across 214 transactions.
- $5.5K Below-median payer
- All-tracks total
- 214 Above-median volume
- Transactions
- 214 Above-median reach
- Recipients
- #1704
- of 1,925 companies
Aquestive Therapeutics, Inc. reported $5,489.18 across all CMS Open Payments tracks (General + Research + Ownership) to 214 physicians and teaching hospitals in Program Year 2024 - ranking #1704 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $5,489.18, averaging $25.65 per recipient.
Aquestive Therapeutics, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
11/100
Total payments
F
10/100
Transaction volume
F
12/100
Physician reach
F
12/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer aquestive-therapeutics-inc Aquestive Therapeutics, Inc.
$5.5K · #1704/1,925 · 0.0% industry · PY2024
- TOT $5.5K
- RANK #1704
- SHARE 0.0%
- TXN 214
- RCP 214
- CAT 1
- GEN $5.5K
- TOP1 1.9%
- PY 2024
Volume peers
Nearest volume peer: Granata Bio Corporation ($5.5K)
Aquestive Therapeutics, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Aquestive Therapeutics, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Aquestive Therapeutics, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 1-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $5.5K, accounting for 100.0% of this company's General Payments and 214 transactions.
General Payment Breakdown by Type
"Food and Beverage" leads Aquestive Therapeutics, Inc.'s 1-category general-payment breakdown at $5.5K, 100.0% of the reported total.
How Aquestive Therapeutics, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $5.5K | 214 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $496.85 (9.1%) of $5,489.18 in this company's General Payments records across 178 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Aquestive Therapeutics, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Vivek U Rao
$103.38 across 1 reported transactions
- 2
Sonali P Majmudar
$103.38 across 1 reported transactions
- 3
Lukena Ulhas Karkhanis
$103.37 across 1 reported transactions
- 4
Dana Wallace
$103.37 across 1 reported transactions
- 5
Mahendra Dadhania
$83.35 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Aquestive Therapeutics, Inc.'s spend rank (#1704 of 1,925, bottom 12% by spend) and concentration rank (#1,718 of 1,838, bottom 7% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Centrix Inc : $17.9K total payments, HHI 84
- Endologix LLC : $725.4K total payments, HHI 84
- Novartis Pharmaceuticals Corporation : $19.7M total payments, HHI 84
- Seapearl East, Inc : $93.9K total payments, HHI 83
- Spinal Elements, Inc. : $50.6K total payments, HHI 83
- Tris Pharma Inc : $742.6K total payments, HHI 83
- Aquestive Therapeutics, Inc. (this company) : $5.5K total payments, HHI 81
- Notal Vision, Inc. : $13.1K total payments, HHI 81
- Atricure, Inc. : $4.9M total payments, HHI 80
- Ipsen Biopharmaceuticals, Inc : $4.5M total payments, HHI 79
- Pinnacle, Inc : $89.6K total payments, HHI 79
- Athena Bioscience, LLC : $2.0K total payments, HHI 78
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Aquestive Therapeutics, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Aquestive Therapeutics, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Aquestive Therapeutics, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Karl Storz Endovision, Inc.
$5.5K 3 recipients
Compare payment profiles
Rare Disease Therapeutics, Inc.
$5.6K 104 recipients
Compare payment profiles
Bridge to Life Ltd
$5.6K 9 recipients
Compare payment profiles
ASD Specialty Healthcare, LLC
$5.3K 60 recipients
Compare payment profiles
Canon Healthcare USA, Inc.
$5.3K 15 recipients
Compare payment profiles
Put this to use
Aquestive Therapeutics, Inc. ranks #1704 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Aquestive Therapeutics, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.